Prostatype Genomics AB (publ)

OM:PROGEN Stock Report

Market Cap: SEK 23.3m

Prostatype Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PROGEN?
Owner TypeNumber of SharesOwnership Percentage
Institutions3,079,9110.311%
Private Companies3,682,5290.372%
Individual Insiders9,409,5030.95%
General Public974,639,24398.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 729.4%.


Top Shareholders

Top 9 shareholders own 1.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.85%
Hakan Englund
8,461,519SEK 198.8k1,100%no data
0.37%
Aj Lundberg KapitalfÖRvaltning Ab
3,682,529SEK 86.5k1,080%no data
0.31%
Creathor Venture Management GmbH
3,079,911SEK 72.4k0%no data
0.064%
Michael Haggman
632,579SEK 14.9k4,170%no data
0.018%
Fredrik Rickman
175,128SEK 4.1k-29.4%no data
0.01%
Jörgen Dahlström
100,000SEK 2.3k0%no data
0.0019%
Michael Winklerfelt
18,848SEK 442.40%no data
0.0012%
Emelie Berglund
11,478SEK 270.10%no data
0.001%
Karlheinz Schmelig
9,951SEK 232.80%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.